BEAM THERAPEUTICS
Beam Therapeutics is a biotechnology company engaged in creating genetic medicines based on its base editing technology. It is pioneering the use of base editing, a potential new class of precision genetic medicines, with a vision of providing life-long cures to patients suffering from serious diseases. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the dna.
BEAM THERAPEUTICS
Industry:
Biotechnology Genetics Medical Therapeutics
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.beamtx.com
Total Employee:
251+
Status:
Active
Total Funding:
689 M USD
Technology used in webpage:
Domain Not Resolving Amazon Amazon Virginia Region COVID-19 Ruby On Rails Token New Relic Envoy Amazon Elastic Load Balancing Akamai Hosted Microsoft Ajax Content Delivery Network
Similar Organizations
Ascidian Therapeutics
Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.
Evogene
Evogene is a biotechnology company developing novel products for life science markets through the use of a unique CPB platform.
Genome Medical
Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.
Maze Therapeutics
Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
REGENXBIO
REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Terremoto Biosciences
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
Variant Bio
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.
Zymeworks
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
2018-11-01
Board_member
Board_member
Current Employees Featured
Giuseppe Ciaramella Chief Scientific Officer & President @ Beam Therapeutics
Chief Scientific Officer & President
2018-02-01
Feng Zhang Co-Founder @ Beam Therapeutics
Co-Founder
Terry-Ann Burrell Chief Financial Officer @ Beam Therapeutics
Chief Financial Officer
Nicole Gaudelli Senior Director, Head of Gene Editing Platform Technologies @ Beam Therapeutics
Senior Director, Head of Gene Editing Platform Technologies
2022-09-01
Christine Swenson Senior Vice President of Regulatory Affairs @ Beam Therapeutics
Senior Vice President of Regulatory Affairs
Sylvia Eash Director, Alliance Management & Business Development @ Beam Therapeutics
Director, Alliance Management & Business Development
2019-05-01
Francine Gregoire Senior Vice President, Head of In vivo Programs @ Beam Therapeutics
Senior Vice President, Head of In vivo Programs
2018-04-01
Suzanne Fleming SVP of Finance @ Beam Therapeutics
SVP of Finance
Christine Bellon Chief Legal Officer @ Beam Therapeutics
Chief Legal Officer
2019-04-01
Manmohan Singh SVP of Pharmaceutical Sciences and Delivery Technologies @ Beam Therapeutics
SVP of Pharmaceutical Sciences and Delivery Technologies
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-02-23 | Guide Therapeutics | Guide Therapeutics acquired by Beam Therapeutics | N/A |
Investors List
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Beam Therapeutics
Casdin Capital
Casdin Capital investment in Post-IPO Equity - Beam Therapeutics
Farallon Capital Management
Farallon Capital Management investment in Post-IPO Equity - Beam Therapeutics
Redmile Group
Redmile Group investment in Post-IPO Equity - Beam Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Post-IPO Equity - Beam Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Beam Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Beam Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Beam Therapeutics
Redmile Group
Redmile Group investment in Series B - Beam Therapeutics
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series B - Beam Therapeutics
Key Employee Changes
Official Site Inspections
http://www.beamtx.com Semrush global rank: 2.07 M Semrush visits lastest month: 9.89 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Beam Therapeutics"
About Us - Beam Therapeutics
Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing lifelong cures to patients suffering from serious diseases. The Beam Team is: …See details»
Careers - Beam Therapeutics
A Message on Applying to Beam. Please be aware that Beam Therapeutics will never initiate contact with applicants via text message nor conduct interviews through messaging apps, …See details»
Press Release - investors.beamtx.com
Dec 7, 2024 This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. …See details»
Beam Therapeutics - Wikipedia
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR and prime editing, whereby single nucleotides in a DNA sequence can be modified without cutting the DNA, theoretically reducin…See details»
Beam Therapeutics - Crunchbase Company Profile
Contact Email info@beamtx.com Beam Therapeutics is a biotechnology company engaged in creating genetic medicines based on its base editing technology. It is pioneering the use of base editing, a potential new class of precision genetic …See details»
INTERNSHIPS AND CO-OPS | Beam Therapeutics - beamtx.com
Beam’s internship and co-op programs are designed for students pursuing degrees such as BS, MS, MBA, PharmD, or PhD, who thrive in a collaborative and fast-paced environment. These …See details»
beamtx.com - Whois.com
Apr 21, 2017 Domain Services Transfer your Domain Consolidate your domains quickly & easily Free With Every Domain Free services included with every domainSee details»
Beam Therapeutics Presents New Non-human Primate (NHP) Data ...
Dec 8, 2024 This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. …See details»
Beam Therapeutics to Present at the 43rd Annual J.P. Morgan …
Dec 17, 2024 A live webcast will be available in the investor section of the company's website at www.beamtx.com and will be archived for 60 d. News. ... Beam is a values-driven organization …See details»
Press Release - investors.beamtx.com
May 17, 2023 This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. …See details»
Company: Beam Therapeutics - CRISPR Medicine
General information. Main focus: Base editing for the treatment of genetic diseases and cancer. Company stage: Pre-clinical. Diseases: Sickle cell disease, beta-thalassemia, acute …See details»
Our Science - Beam Therapeutics
In 2017, Beam Therapeutics was founded by gene editing pioneers with a goal of creating precision genetic medicines with base editing. Beam is a values-driven organization with a …See details»
Beam Therapeutics to Participate in Jefferies Global Healthcare ...
May 30, 2024 A live webcast will be available in the investor section of the company's website at www.beamtx.com, and will be archived for 60 days following the presentation. About Beam …See details»
Fellowships - Beam Therapeutics
Contact Information: careers@beamtx.com . Meet the Beam Team Watch video. Application and Selection Process . ... for additional rounds of interviews that will include meetings with cross …See details»
Meta Follows Elon Musk’s Lead, Moves Staffers to Billionaire …
22 hours ago At the time, Texas attorney general Ken Paxton also announced his office was opening an investigation into the organization. A federal judge in Texas refused to throw out …See details»
Manufacturing Associate / Sr. Manufacturing Associate
This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven …See details»
Beam Therapeutics to Present at the SVB Leerink 11th Annual …
Feb 9, 2022 A live webcast will be available in the investor section of the company's website at www.beamtx.com, and will be archived for 60 days following the presentation. About Beam …See details»
Curing serious diseases one letter at a time | Beam Therapeutics
Inclusion of these resources does not indicate endorsement by Beam Therapeutics of an organization or its communications. The list is not intended as a comprehensive list of …See details»
Press Release - Beam Therapeutics
CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base …See details»
Beam Therapeutics to Participate in the 2021 William Blair Biotech ...
Jul 8, 2021 The live webcast will be available in the investor section of the company's website at www.beamtx.com. The webcast will be archived for 60 days following the presentation. ...See details»